
CVSA Stock Forecast & Price Target
CVSA Analyst Ratings
Bulls say
Covista is expected to see growth in their Chamberlain segment, leading to an increase in their price target. The company has reported strong financial performance and raised their outlook for the year, with a focus on addressing labor shortages in the healthcare industry. However, there are potential risks and headwinds that could impact the company's performance. Overall, the company is seen as a strong investment opportunity with a Buy rating and expected growth potential.
Bears say
Covista is facing several headwinds, including regulatory challenges, missing long-term targets, and a potential decline in enrollment at Chamberlain University's nursing programs. This could lead to a slow-down in overall enrollment growth and pressure on the company's financials. Additionally, increased competition in the education space could also impact Covista's market share and profitability.
This aggregate rating is based on analysts' research of Adtalem Global Education Inc and is not a guaranteed prediction by Public.com or investment advice.
CVSA Analyst Forecast & Price Prediction
Start investing in CVSA
Order type
Buy in
Order amount
Est. shares
0 shares